Melsmon Pharmaceutical Co., Ltd.
Melsmon
Brand
Melsmon Pharmaceutical Co., Ltd.
Category
IV Therapy
Origin
Korea
Interested in ordering Melsmon? Send an enquiry and our team will follow up with availability and pricing.
Used in
Overview
Melsmon is a human placenta extract injection produced by Melsmon Pharmaceutical Co., Ltd. of Japan, where it has a long history of clinical use. It is widely used internationally within revitalisation, anti-ageing and hormonal-wellness protocols. As a human-derived biologic, its regulatory status and permitted use vary substantially by country and must be verified locally.
How it works
Melsmon is a hydrolysate of human placenta containing a complex mixture of amino acids, peptides, vitamins, minerals, sugars and enzymes. It is marketed for cellular revitalisation and support of menopausal and general wellbeing, with proposed activity in tissue support and metabolic balance. As with other placental extracts, mechanistic claims are marketing-oriented and evidence and approvals differ by jurisdiction.
Indications
- Revitalisation and anti-ageing support
- Menopausal and general wellbeing support (per Japanese market positioning)
- Fatigue and recovery support
- Skin quality and rejuvenation protocols
- General vitality and wellness programmes
Key features
- Human placenta extract, 100 mg / 2 mL ampoule
- Manufactured by Melsmon Pharmaceutical Co., Ltd., Japan
- Long-established clinical history in Japan
- Administered SC or IM
- 50-ampoule presentation
Benefits
- Recognised Japanese-origin placental extract for premium revitalisation menus
- Established manufacturer supports provenance and repeat supply
- Aligns with anti-ageing and hormonal-wellness positioning
- Bulk 50-ampoule pack suits course-based protocols
- Single-use ampoules support controlled administration
Composition
Human placenta extract (hydrolysate) 100 mg per 2 mL ampoule; typically supplied as 2 mL x 50 ampoules. Formulation includes benzyl alcohol as preservative.
Usage & handling
Administered subcutaneously or intramuscularly under medical supervision. IMPORTANT: as a human placenta-derived biologic, regulatory status varies by country - it is restricted or unapproved in some jurisdictions, and recipients may face blood/plasma donation deferral in certain countries. Note the benzyl alcohol content when treating sensitive populations. Verify national regulatory approval, import rules and donation-deferral implications before any clinical use.
For medical professionals. Product information is for reference and does not replace the manufacturer's instructions for use. Availability and regulatory status vary by region.